Published in Cancer Epidemiol Biomarkers Prev on July 20, 2010
E-cigarettes: a scientific review. Circulation (2014) 7.99
e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health (2012) 7.71
Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control (2013) 7.69
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One (2013) 6.44
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health (2011) 5.43
Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control (2013) 5.08
"Smoking revolution": a content analysis of electronic cigarette retail websites. Am J Prev Med (2014) 4.91
Electronic nicotine delivery systems: a research agenda. Tob Control (2011) 4.21
Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res (2012) 3.55
Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev (2012) 3.42
E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res (2013) 3.14
Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction (2014) 3.00
Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep (2014) 2.97
Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health (2013) 2.83
Electronic cigarette use by college students. Drug Alcohol Depend (2013) 2.80
Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction (2014) 2.73
Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res (2013) 2.39
Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health (2014) 2.37
Electronic cigarettes: human health effects. Tob Control (2014) 2.34
Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) (2013) 2.28
Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers. Addict Behav (2014) 2.16
Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res (2014) 1.98
A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J (2013) 1.93
Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health (2013) 1.93
Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health (2013) 1.71
Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse (2013) 1.69
Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 1.62
Electronic nicotine delivery systems ("e-cigarettes"): review of safety and smoking cessation efficacy. Otolaryngol Head Neck Surg (2014) 1.58
Non-cigarette tobacco products: what have we learnt and where are we headed? Tob Control (2012) 1.58
The scientific foundation for tobacco harm reduction, 2006-2011. Harm Reduct J (2011) 1.57
Electronic cigarette effectiveness and abuse liability: predicting and regulating nicotine flux. Nicotine Tob Res (2014) 1.48
Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health (2014) 1.47
Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob Res (2014) 1.44
E-cigarettes--prevention, pulmonary health, and addiction. Dtsch Arztebl Int (2014) 1.43
Electronic cigarettes and nicotine clinical pharmacology. Tob Control (2014) 1.28
Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front Public Health (2013) 1.27
Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res (2014) 1.23
Use and perception of electronic cigarettes among college students. J Am Coll Health (2013) 1.23
Dependence on tobacco and nicotine products: a case for product-specific assessment. Nicotine Tob Res (2012) 1.22
Factors Associated With Electronic Cigarette Users' Device Preferences and Transition From First Generation to Advanced Generation Devices. Nicotine Tob Res (2015) 1.19
Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health (2013) 1.18
Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychopharmacology (Berl) (2013) 1.16
Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res (2014) 1.15
Electronic cigarettes: what are they and what do they do? Ann N Y Acad Sci (2016) 1.13
Electronic cigarettes: abuse liability, topography and subjective effects. Tob Control (2014) 1.12
Science and electronic cigarettes: current data, future needs. J Addict Med (2014) 1.11
Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control (2015) 1.05
Vaporous Marketing: Uncovering Pervasive Electronic Cigarette Advertisements on Twitter. PLoS One (2016) 1.03
Initial puffing behaviors and subjective responses differ between an electronic nicotine delivery system and traditional cigarettes. Tob Induc Dis (2014) 1.02
E-cigarettes: online survey of UK smoking cessation practitioners. Tob Induc Dis (2014) 1.02
Knowledge About E-Cigarette Constituents and Regulation: Results From a National Survey of U.S. Young Adults. Nicotine Tob Res (2014) 1.00
Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis. BMC Public Health (2014) 0.99
Overview of Electronic Nicotine Delivery Systems: A Systematic Review. Am J Prev Med (2016) 0.95
Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci Rep (2015) 0.95
Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction (2015) 0.94
Science and the evolving electronic cigarette. Prev Med (2015) 0.94
Adolescents' and Young Adults' Perceptions of Electronic Cigarettes for Smoking Cessation: A Focus Group Study. Nicotine Tob Res (2015) 0.93
Effects of duration of electronic cigarette use. Nicotine Tob Res (2014) 0.92
Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis (2014) 0.91
Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced Airway Inflammation and Hyper-responsiveness in Mice. Toxicol Res (2014) 0.91
Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes). Risk Manag Healthc Policy (2015) 0.88
A decade of e-cigarettes: Limited research & unresolved safety concerns. Toxicology (2016) 0.88
Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. Front Psychiatry (2013) 0.87
A Randomized Trial Comparing the Effect of Nicotine Versus Placebo Electronic Cigarettes on Smoking Reduction Among Young Adult Smokers. Nicotine Tob Res (2016) 0.87
Electronic nicotine delivery devices, and their impact on health and patterns of tobacco use: a systematic review protocol. BMJ Open (2015) 0.86
Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Med (2015) 0.85
Nicotine levels in electronic cigarette refill solutions: A comparative analysis of products from the U.S., Korea, and Poland. Int J Drug Policy (2015) 0.85
The electronic cigarette: the new cigarette of the 21st century? J Bras Pneumol (2014) 0.83
Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes. BMC Public Health (2015) 0.83
Nicotine flux: a potentially important tool for regulating electronic cigarettes. Nicotine Tob Res (2014) 0.81
The importance of science-informed policy and what the data really tell us about e-cigarettes. Isr J Health Policy Res (2015) 0.80
The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers. Psychol Addict Behav (2015) 0.79
Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Toxicol Mech Methods (2016) 0.79
Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes. Drug Alcohol Depend (2016) 0.78
Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products. Fluids Barriers CNS (2015) 0.78
Nicotine and cotinine exposure from electronic cigarettes: a population approach. Clin Pharmacokinet (2015) 0.77
Commentary on Brose et al. (2015): Protecting individual and public health by regulating electronic cigarette nicotine delivery. Addiction (2015) 0.77
A transdisciplinary model to inform randomized clinical trial methods for electronic cigarette evaluation. BMC Public Health (2016) 0.77
Reasons for using flavored liquids among electronic cigarette users: A concept mapping study. Drug Alcohol Depend (2016) 0.76
Water pipe steam stones: familiarity and use among US young adults. Nicotine Tob Res (2014) 0.75
Evaluation of a novel nicotine inhaler device: part 1--arterial and venous pharmacokinetics. Nicotine Tob Res (2014) 0.75
Cue-reactivity in experienced electronic cigarette users: Novel stimulus videos and a pilot fMRI study. Brain Res Bull (2015) 0.75
A Prototypical First-Generation Electronic Cigarette Does Not Reduce Reports of Tobacco Urges or Withdrawal Symptoms among Cigarette Smokers. J Addict (2017) 0.75
Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers. Drug Alcohol Depend (2016) 0.75
Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health (2016) 0.75
Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa. Pulm Med (2016) 0.75
Nicotine Replacement, Topography, and Smoking Phenotypes of E-cigarettes. Tob Regul Sci (2016) 0.75
Electronic cigarettes. CMAJ (2013) 0.75
The Importance of Conditioned Stimuli in Cigarette and E-Cigarette Craving Reduction by E-Cigarettes. Int J Environ Res Public Health (2017) 0.75
Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol (2017) 0.75
Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes. Drug Alcohol Depend (2017) 0.75
Assessing electronic cigarette effects and regulatory impact: Challenges with user self-reported device power. Drug Alcohol Depend (2017) 0.75
Impact of Electronic Cigarettes on the Cardiovascular System. J Am Heart Assoc (2017) 0.75
Foods are differentially associated with subjective effect report questions of abuse liability. PLoS One (2017) 0.75
Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges. Tob Regul Sci (2016) 0.75
Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res (2001) 8.36
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control (2010) 7.97
Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure. Am J Prev Med (2009) 4.20
Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control (2010) 4.03
Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res (2006) 2.75
Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction (2005) 2.57
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol (2008) 2.44
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tob Control (2009) 2.17
Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med (2005) 1.90
Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine Tob Res (2002) 1.84
Test marketing of new smokeless tobacco products in four U.S. cities. Nicotine Tob Res (2009) 1.78
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ (1995) 1.70
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59
Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control (1999) 1.58
Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health (2004) 1.56
Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tob Control (2001) 1.53
Electronic cigarettes: safety concerns and regulatory issues. Am J Health Syst Pharm (2009) 1.39
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res (2008) 1.36
Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. Nicotine Tob Res (2001) 1.35
Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications. Nicotine Tob Res (2007) 1.27
Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example. Cancer Epidemiol Biomarkers Prev (2009) 1.24
New tobacco products: do smokers like them? Tob Control (2006) 1.21
Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology. Nicotine Tob Res (2008) 1.18
The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure. Nicotine Tob Res (2004) 1.13
Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology (Berl) (1996) 1.10
Evaluating oral noncombustible potential-reduced exposure products for smokers. Nicotine Tob Res (2010) 1.08
Measures for assessing subjective effects of potential reduced-exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Acute effects of nicotine on resting metabolic rate in cigarette smokers. Am J Clin Nutr (1989) 1.04
The time for tobacco industry sponsored PREP evaluation has arrived. Tob Control (2006) 0.96
Prevalence of and associations with waterpipe tobacco smoking among U.S. university students. Ann Behav Med (2008) 4.24
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol (2008) 2.44
Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob Res (2010) 2.26
Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 1.62
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59
Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res (2006) 1.47
Does switching to a tobacco-free waterpipe product reduce toxicant intake? A crossover study comparing CO, NO, PAH, volatile aldehydes, "tar" and nicotine yields. Food Chem Toxicol (2012) 1.43
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res (2008) 1.36
Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug Alcohol Depend (2011) 1.34
Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res (2009) 1.30
Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag (2008) 1.22
Significance of smoking machine toxicant yields to blood-level exposure in water pipe tobacco smokers. Cancer Epidemiol Biomarkers Prev (2011) 1.09
Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07
Addiction and pain. Am J Addict (2003) 1.03
Patterns of alternative tobacco use among adolescent cigarette smokers. Drug Alcohol Depend (2011) 1.02
Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav (2002) 0.98
Facebook apps for smoking cessation: a review of content and adherence to evidence-based guidelines. J Med Internet Res (2014) 0.96
Trends in alternative tobacco use among light, moderate, and heavy smokers in adolescence, 1999-2009. Addict Behav (2012) 0.94
Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study. BMC Anesthesiol (2007) 0.91
Predictors of involvement in the juvenile justice system among psychiatric hospitalized adolescents. Addict Behav (2008) 0.86
How to freak a Black & Mild: a multi-study analysis of YouTube videos illustrating cigar product modification. Health Educ Res (2013) 0.84
The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention. Am J Public Health (2010) 0.83
A multiple indicators and multiple causes model of alternative tobacco use. Am J Health Behav (2013) 0.83
Balancing Beneficence and Autonomy. Am J Bioeth (2015) 0.75
Responsible opioid use. J Pain Palliat Care Pharmacother (2015) 0.75
Opioid Analgesics and Nicotine: More Than Blowing Smoke. J Pain Palliat Care Pharmacother (2015) 0.75
Factors related to injection drug use among female prisoners. Subst Use Misuse (2010) 0.75